Human KCNQ5 de novo Mutations Underlie Epilepsy and Intellectual Disability.

We identified six novel de novo human KCNQ5 variants in children with motor/language delay, intellectual disability (ID) and/or epilepsy by whole-exome sequencing. These variants comprised of two nonsense and four missense alterations, were functionally characterized by electrophysiology in HEK293/CHO cells, together with four previously reported KCNQ5 missense variants (Lehman, et al., 2017). Surprisingly, all eight missense variants resulted in gain-of-function (GOF) due to hyperpolarized voltage-dependence of activation or slowed deactivation kinetics, while the two nonsense variants were confirmed to be loss-of-function (LOF). One severe GOF allele (P369T) was tested and found to extend a dominant GOF effect to heteromeric KCNQ5/3 channels. Clinical presentations were associated with altered KCNQ5 channel gating: Milder presentations with LOF or smaller GOF shifts in voltage-dependence (DV50= ~-15 mV), and severe presentations with larger GOF shifts in voltage-dependence (DV50= ~-30 mV). To examine LOF pathogenicity, two Kcnq5 LOF mouse lines were created using CRISPR/Cas9. Both lines exhibited handling- and thermal-induced seizures, and abnormal cortical EEGs consistent with epileptiform activity. Our study thus provides evidence for in vivo KCNQ5 LOF pathogenicity and strengthens the contribution of both LOF and GOF mutations to global pediatric neurological impairment, including ID/epilepsy.

[1]  E. Cooper,et al.  KCNQ channel PIP2 modulation: Two loose links, three rings, and a twist , 2022, Neuron.

[2]  Tian Li,et al.  Structural Basis for the Modulation of Human KCNQ4 by Small-Molecule Drugs. , 2020, Molecular cell.

[3]  Jie Fu,et al.  Molecular basis for ligand activation of the human KCNQ2 channel , 2020, Cell research.

[4]  G. Abbott,et al.  KCNQ5 activation is a unifying molecular mechanism shared by genetically and culturally diverse botanical hypotensive folk medicines , 2019, Proceedings of the National Academy of Sciences.

[5]  A. Puliti,et al.  Intragenic duplication of KCNQ5 gene results in aberrant splicing leading to a premature termination codon in a patient with intellectual disability. , 2019, European journal of medical genetics.

[6]  M. Farrer,et al.  Loss-of-Function and Gain-of-Function Mutations in KCNQ5 Cause Intellectual Disability or Epileptic Encephalopathy. , 2017, American journal of human genetics.

[7]  C. Luo,et al.  Pro-arrhythmogenic Effects of the V141M KCNQ1 Mutation in Short QT Syndrome and Its Potential Therapeutic Targets: Insights from Modeling , 2017, Journal of medical and biological engineering.

[8]  R. MacKinnon,et al.  Cryo-EM Structure of a KCNQ1/CaM Complex Reveals Insights into Congenital Long QT Syndrome , 2017, Cell.

[9]  Rebecca C. Spillmann,et al.  Neonatal nonepileptic myoclonus is a prominent clinical feature of KCNQ2 gain‐of‐function variants R201C and R201H , 2017, Epilepsia.

[10]  William A. Catterall,et al.  Sleep impairment and reduced interneuron excitability in a mouse model of Dravet Syndrome , 2015, Neurobiology of Disease.

[11]  Dietmar Schmitz,et al.  KCNQ5 K+ channels control hippocampal synaptic inhibition and fast network oscillations , 2015, Nature Communications.

[12]  Christian Gilissen,et al.  A Post‐Hoc Comparison of the Utility of Sanger Sequencing and Exome Sequencing for the Diagnosis of Heterogeneous Diseases , 2013, Human mutation.

[13]  L. Kaczmarek,et al.  De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy , 2012, Nature Genetics.

[14]  L. Trussell,et al.  KCNQ5 channels control resting properties and release probability of a synapse , 2011, Nature Neuroscience.

[15]  Theofanis Karayannis,et al.  Neuronal activity is required for the development of specific cortical interneuron subtypes , 2011, Nature.

[16]  E. Cooper.  Made for "anchorin": Kv7.2/7.3 (KCNQ2/KCNQ3) channels and the modulation of neuronal excitability in vertebrate axons. , 2011, Seminars in cell & developmental biology.

[17]  Anastassios V. Tzingounis,et al.  The KCNQ5 potassium channel mediates a component of the afterhyperpolarization current in mouse hippocampus , 2010, Proceedings of the National Academy of Sciences.

[18]  O. Pongs,et al.  Intracellular domains interactions and gated motions of IKS potassium channel subunits , 2009, The EMBO journal.

[19]  M. Leppert,et al.  Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization , 2008, The Journal of physiology.

[20]  Daniel L. Minor,et al.  Structural Insight into KCNQ (Kv7) Channel Assembly and Channelopathy , 2007, Neuron.

[21]  Tobias Meyer,et al.  Rapid Chemically Induced Changes of PtdIns(4,5)P2 Gate KCNQ Ion Channels , 2006, Science.

[22]  L. Langeberg,et al.  AKAP150 signaling complex promotes suppression of the M-current by muscarinic agonists , 2003, Nature Neuroscience.

[23]  C. Petit,et al.  KCNQ4, a K+ channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  B S Brown,et al.  KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. , 1998, Science.

[25]  M. Blanar,et al.  Functional Expression of Two KvLQT1-related Potassium Channels Responsible for an Inherited Idiopathic Epilepsy* , 1998, The Journal of Biological Chemistry.

[26]  Mark Leppert,et al.  A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns , 1998, Nature Genetics.

[27]  G. Landes,et al.  Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias , 1996, Nature Genetics.

[28]  D. A. Brown,et al.  Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone , 1980, Nature.